Medication-Use Evaluation of Recombinant Human Factor VIIa
Introduction: Medication-use evaluation (MUE) is a performance improvement method used to achieve optimal patient outcomes. The recombinant human factor VIIa (rFVIIa) (NovoSeven) is an expensive agent approved by the U.S. Food and Drug Administration (FDA) for specific indications. However, in clini...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Innovative Healthcare Institute
2020-05-01
|
| Series: | Global Journal on Quality and Safety in Healthcare |
| Subjects: | |
| Online Access: | https://jqsh.org/doi/pdf/10.36401/JQSH-19-41 |